Daleen Thomas - Concepedia

Author

Daleen Thomas

Also Known As

D. Thomas, D.A. THOMAS, Daleen Thomas, S. Suciu

Publications

141

Citations

H-Index

Concepts

All Affiliations

Daleen Thomas is an author at Clovis Oncology (United States) specializing in radiation oncology, immunology, and cancer genetics.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	28
2	Immunology	1	1	28
3	Pathology	1	1	28
4	Cancer Genetics	1	1	28
5	Cancer Therapeutics	1	1	28

Daleen Thomas

Publications

133

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS) Petros Grivas, Yohann Loriot, Rafael Morales‐Barrera, BMC Cancer	2021	57
Rucaparib for recurrent, locally advanced, or metastatic urothelial carcinoma (mUC): Results from ATLAS, a phase II open-label trial. Petros Grivas, Yohann Loriot, Susan Feyerabend, Journal of Clinical Oncology Unknown Hrd StatusUrologyMetastatic Urothelial CarcinomaParp InhibitorMalignant Disease	2020	28
Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer H. T. See, Daleen Thomas, Carlos Bueso-Ramos, International Journal of Gynecological Cancer	2006	20
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial Amit M. Oza, Alla Lisyanskaya, Alexander N. Fedenko, The Lancet Oncology	2025	15
1Rucaparib versus chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: efficacy and safety from ARIEL4, a randomized phase III study Rebecca Kristeleit, Alla Lisyanskaya, Alexander N. Fedenko, Gynecologic Oncology	2021	13

Page 1